Significados de fabry's disease en inglés

Recent advances in enzyme replacement therapy can reverse the storage of glycosphingolipids in Fabry's disease.

The diagnosis of Fabry's disease was made by the absence of plasma alpha-galactosidase A activity.

Thus, in patients with cardiac hypertrophy, it is important to differentiate Fabry's disease from other causes of hypertrophy.

This was a very rare case of subclinical Fabry's disease coexistent with cholesterol crystal embolization, mimicking pulmonary-renal syndrome.